Watch Ticker

TG Therapeutics, Inc.

Go to TG Therapeutics, Inc. Website

$28.91

0.19 (0.66%)

Live

Previous Close

$28.72

Day Range

$0 - $0

Previous Day Range

$28.28 - $32.1999

Market Cap

$5.6 billion USD

Day Vol.

Previous Day Vol.

11.4 million

Currency

USD

Primary Exchange

Nasdaq

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Dr...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - TG Therapeutics Q2 Revenue Up 91%

TG Therapeutics reported strong Q2 2025 results with BRIUMVI sales growth, raising full-year revenue guidance to $585 million. The company is focusing on expanding product reach, developing new dosing regimens, and exploring additional indications for its multiple sclerosis therapy.

Related tickers: TGTX, RHHBY.

Read Full Article

N/A - TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

TG Therapeutics reported strong Q1 2025 financial results for its multiple sclerosis drug BRIUMVI, with $119.7 million in U.S. net sales and raised its full-year revenue guidance. The company also provided updates on its pipeline, including plans to advance subcutaneous BRIUMVI and a new therapy for progressive MS.

Related tickers: TGTX.

Read Full Article

Trending Tickers

Please sign in to view